INKT - MiNK Therapeutics, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
13.97 0.83 (5.96%)	---	---	---	0.0 (0.0%)	0.65 (4.59%)	0.0 (0.0%)	-0.07 (-0.51%)

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Market Period: Closed

Earnings & Ratios

Basic EPS:: -1.06
Diluted EPS:: -1.06
Basic P/E:: -13.9623
Diluted P/E:: -13.9623
RSI(14) 1m:: 31.9
VWAP:: 14.79
RVol:: 0.5959

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	14.9 +0.27 (+1.82%)	Oct 15 15:45
1m	Price increase 1m	14.48 +0.31 (+2.19%)	Oct 15 09:40
1m	Price decrease 1m	14.0 -0.15 (-1.06%)	Oct 15 09:30